Liver Cancer Research

At Fred Hutch, our liver cancer researchers create new models of the disease in order to better understand the genetic changes that drive it. They pinpoint the biomarkers that will improve detection. And they test drug therapies to improve outcomes for patients.

 

Researchers and Patient Treatments

Dr. Bill Grady

Our Liver Cancer Researchers

Our interdisciplinary scientists and clinicians work together to prevent, diagnose and treat liver cancer as well as other cancers and diseases.

Meet Our Faculty
father talking wiht daughter

Patient Treatment and Care

At Fred Hutch, our interdisciplinary teams work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Our aim is to provide patients access to advanced treatment options while getting the best cancer care.

Request An Appointment

Selected Liver Cancer Clinical Trials

Clinical research is an essential part of the scientific process that leads to new treatments and better care. Clinical trials can also be a way for patients to get early access to new 
cutting-edge therapies. Our clinical research teams are running clinical studies on various kinds of liver cancer.

Liver Cancer Research

Our researchers study the molecular mechanisms behind liver tumor formation and the factors that affect liver cancer development. They aim to use these findings to advance early detection and diagnosis. Our scientists also study the factors that affect whether a particular treatment works for a given patient. Our clinical trials test new and experimental drug therapies.

Earlier Detection

HCC is the third most common cause of cancer-related death. High mortality rates stem in part from the difficulty of detecting HCC in its early stages. Our researchers are developing better ways to identify liver cancer earlier when it is easier to treat.

Hepatitis B and C

The hepatitis B and C viruses can cause liver cancer. Because infection is common, liver cancer will remain a major public health threat. Fred Hutch researchers are studying several aspects of hepatitis B and C viruses, with the aim of preventing liver cancer. For example, they are studying how the viruses are transmitted and how they affect cancer patients with compromised immune systems. Our researchers are also developing new techniques to cure hepatitis infection using gene-editing techniques.

New Drug Targets

The hepatitis B and C viruses can cause liver cancer. Because infection is common, liver cancer will remain a major public health threat. Fred Hutch researchers are studying several aspects of hepatitis B and C viruses, with the aim of preventing liver cancer. For example, they are studying how the viruses are transmitted and how they affect cancer patients with compromised immune systems. Our researchers are also developing new techniques to cure hepatitis infection using gene-editing techniques.

Latest Liver Cancer News

MORE LIVER CANCER NEWS
Making the most of a small supply Fred Hutch researchers receive $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day September 30, 2024
Finding a rare bile duct cancer’s weaknesses DOD and Cholangiocarcinoma Foundation awards will help Dr. Debraj Boila reveal genetics, drug targets of intrahepatic cholangiocarcinoma July 30, 2024
$5.25M from the Kuni Foundation propels innovative adult oncology research Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies June 28, 2024
Mapping a pathway to hope How Fred Hutch researchers revealed the biology behind a drug’s success in a rare liver cancer and paired it with another drug for a one-two punch June 4, 2024